FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN
Updated COVID-19 booster targets subvariants responsible for 98% of cases today : Oregon Health News Blog
Bivalent COVID Shots May Hold Up Better Against Severe Omicron | MedPage Today
Potentially breaking the COVID-19 stalemate with variant booster, bivalent or polyvalent vaccines
Updated COVID booster tied to strong Omicron immune response | CIDRAP
Bivalent COVID-19 mRNA Booster Effective - Southern Iowa Mental Health Center
New Omicron-specific vaccines offer similar protection to existing boosters
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Boosting with updated COVID-19 mRNA vaccines | Nature Medicine
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet Infectious Diseases
Effectiveness of Vaccination and Previous Infection Against Omicron Infection and Severe Outcomes in Children Under 12 Years of Age | medRxiv
Why and When to Get a Bivalent Covid-19 Booster | Johns Hopkins | Bloomberg School of Public Health
COVID-19 bivalent booster effectiveness in people with and without immune dysfunction L
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 | MMWR
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
NEJM on X: "Figure 1. Effectiveness of Bivalent Boosters According to the Interval since Administration. https://t.co/hIVtIujZoq #Covid19 https://t.co/KBljA6y7NR" / X
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
The effectiveness of a bivalent COVID-19 mRNA booster dose against hospitalization
New Omicron-specific vaccines offer similar protection to existing boosters
Studies show real-world usefulness of bivalent COVID boosters | CIDRAP
Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged ≥50 years in Ontario, Canada | medRxiv
Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population | Nature Medicine
FDA clears the way for additional bivalent boosters for certain vulnerable individuals | CNN
Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study - The Lancet Infectious Diseases
